• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Sodium-glucose cotransporter-2 inhibitors may be linked to Fournier gangrene

byEmily JiandDeepti Shroff Karhade
June 10, 2019
in Chronic Disease, Dermatology, Emergency, Endocrinology, Public Health, Surgery, Urology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this descriptive case series, 55 cases of patients with diabetes who developed Fournier gangrene while using sodium-glucose cotransporter-2 (SGLT2) inhibitors are described.

2. While neither causality nor incidence are identified in this paper, physicians prescribing SGLT2 inhibitors should be aware of the association with Fournier gangrene.

Evidence Rating Level: 4 (Below Average)

Study Rundown: Fournier gangrene (FG) is a rapidly progressive necrotizing fasciitis of the perineum, external genitalia, and perianal region that requires immediate broad-spectrum antibiotics and surgical intervention. While some risk factors such as HIV status, alcoholism, and diabetes mellitus (DM) have been described, FG is extremely rare and remains poorly understood. Recently, the FDA issued warnings that sodium-glucose cotransporter-2 (SGLT2) medications for DM could be associated with FG. This study reviewed and described 55 reported cases of adults who developed FG while also taking SGLT2 inhibitors. The time from initiation of SGLT2 and FG onset were variable, as were associated complications. As this study was purely descriptive, there were many limitations. There was no establishment of causality or incidence. Further, the data was limited by the voluntary nature of incident reporting, thus leading to variable quality of the reports, underreporting, and confounding by indication.

Click to read the study in Annals of Internal Medicine

Relevant Reading: FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes

RELATED REPORTS

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes

Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

In-Depth [descriptive case-series]: The authors used the FDA Adverse Event Reporting System (FAERS), a database of adverse drug events voluntarily reported by health care providers, as well as published cases reports, to identify 55 cases of FG after SGLT2 therapy. Age of patients ranged from 33-87 years, with 39 men and 19 women. Time from initiation of SGLT2 therapy to development of FG ranged from 5 days to 49 months. Common complications in the order of prevalence included sepsis (n=9), diabetic ketoacidosis (n=8), fecal diversion surgery (n=8), acute kidney injury (n=4), and death (n=3). Comparatively, only 19 cases of FG associated with other antiglycemic agents were identified by the FDA between 1984 and 2019. The patients were between the ages of 42 and 79, and were on metformin (n=8), short-acting insulin (n=2), insulin glargine (n-6) and dulaglutide (n=1). Of these patients, two died. The results of this study showed that in patients receiving SGLT2 inhibitors, physicians should be aware of complications such as FG and be able to diagnose them during their early stages.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Fournier gangreneinsulinmetforminsglt2 inhibitorsType 2 Diabetes Mellitus
Previous Post

Quick Take: Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER)

Next Post

PET scans show high tau levels in former NFL players with potential chronic traumatic encephalopathy

RelatedReports

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes
StudyGraphics

#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes

July 7, 2025
Compliance-linked incentives increase infant immunizations rates in rural India
Endocrinology

Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes

June 16, 2025
Increased number of daily steps linked with decreased mortality in older women
Chronic Disease

Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes

May 29, 2025
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Increased tirzepatide use for glycemic and weight control since United States market entry

April 14, 2025
Next Post
Researchers validate scoring of postconcussive symptom measure to characterize duration 

PET scans show high tau levels in former NFL players with potential chronic traumatic encephalopathy

#VisualAbstract: Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

#VisualAbstract: Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers

Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren

Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Oral vancomycin may be effective for pouchitis in inflammatory bowel disease
  • Inebilizumab improves outcome in patients generalized myasthenia gravis
  • Medbridge turns any phone into a motion-capture coach for at-home rehab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.